Swarajya

Our View
HeadlinesMagazineVideosBooksस्वराज्यEconomyCultureEvents
User Profile
Subscribe
Swarajya
Subscribe
  • Our View
  • Headlines
  • Magazine
Swarajya
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief
  • Subscriber login
  • Politics
  • Economics
  • Business
  • Culture
  • Books & Ideas
  • World
  • Defence
  • Energy & Infrastructure
  • Science
  • Technology
  • Heritage
  • Videos
  • Podcasts
  • Archives
  • Blogs
  • News Brief

Indian pharma industry

Dr Reddy’s Enters Into Voluntary Licensing Agreement To Manufacture Baricitinib Used For Covid-19 Treatment
Dr Reddy’s Enters Into Voluntary Licensing Agreement To Manufacture Baricitinib Used For Covid-19 TreatmentSwarajya StaffMay 12, 2021 01:16 PM +05:30 IST
From Being A Net Importer, India Now Manufactures Over 5 Lakh PPE Kits Per Day: Union Minister Sadananda Gowda
From Being A Net Importer, India Now Manufactures Over 5 Lakh PPE Kits Per Day: Union Minister Sadananda GowdaSwarajya StaffSep 18, 2020 09:15 AM +05:30 IST
India’s Next Big Plan To Boycott Chinese Pharma Imports
India’s Next Big Plan To Boycott Chinese Pharma ImportsSwarajya VideosJul 23, 2020 08:53 PM +05:30 IST
One Each For Import And Export: How Over-Dependence On China And US Markets Blocks Indian Pharma’s Growth
One Each For Import And Export: How Over-Dependence On China And US Markets Blocks Indian Pharma’s Growth Karan BhasinApr 16, 2020 03:50 PM +05:30 IST
Paracetamol Prices Surge By 40 Per Cent In India As Coronavirus Outbreak Puts China On A Shutdown
Paracetamol Prices Surge By 40 Per Cent In India As Coronavirus Outbreak Puts China On A ShutdownSwarajya StaffFeb 18, 2020 11:29 AM +05:30 IST
Get Your Drugs Online Now, But Under Strict Central Supervision; Draft Rules For E-Pharmacies Now In Place
Get Your Drugs Online Now, But Under Strict Central Supervision; Draft Rules For E-Pharmacies Now In PlaceSwarajya StaffDec 12, 2018 12:30 PM +05:30 IST
In The Pink Of Health: India’s Generic Drug Exporters On A Growth Curve
In The Pink Of Health: India’s Generic Drug Exporters On A Growth CurveAmriteshwar MathurSep 25, 2018 01:45 PM +05:30 IST
Gujarat Emerges As The Number One State In Manufacturing Quality Medicines In India
Gujarat Emerges As The Number One State In Manufacturing Quality Medicines In IndiaSwarajya StaffJul 23, 2018 05:13 PM +05:30 IST
Delhi HC Quashes Centre’s Ban On 344 FDC Medicines After Pharma Company Petitions
Delhi HC Quashes Centre’s Ban On 344 FDC Medicines After Pharma Company PetitionsSwarajya StaffDec 1, 2016 04:35 PM +05:30 IST
 Indian Pharma Sector Gets A Thumbs-Up From Moody’s
Indian Pharma Sector Gets A Thumbs-Up From Moody’sSwarajya StaffNov 25, 2016 08:56 PM +05:30 IST
 Why Indian Pharma Sector Should Move From Generic To Innovation
Why Indian Pharma Sector Should Move From Generic To InnovationNilanjan Banik and Philip StevensMay 3, 2016 01:32 PM +05:30 IST
Does India Really Need to Amend its Patent Law?
Does India Really Need to Amend its Patent Law?SaideepakApr 26, 2015 01:20 PM +05:30 IST
Load More

About Swarajya

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Fact Check
  • Gift Swarajya
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Advertise
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.Artboard 2 Copy 10Created with Sketch.Artboard 2 Copy 7Created with Sketch.Artboard 2 Copy 9Created with Sketch.
Copyright: Swarajya. All Rights Reserved.
Powered by Quintype